USPTO serial 90818802
COVERMYMEDS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 31, 2024
- Examiner
- BROWNING, KATHRYN ELISABETH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with COVERMYMEDS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Auma N. Reggy
Auma N. Reggy MCKESSON CORPORATION2 NATIONAL DATA PLAZA, NEATLANTA, GA 30329United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 036 | Financial administration of pharmaceutical manufacturer program that redeploys rebate funds directly to underinsured or uninsured consumers at the pharmacy counter; providing a patient financial assistance and financial support program for patients and their healthcare providers for the purpose of facilitating good health, namely, providing financial information about medication, access to medical care, medication insurance coverage, benefits verification, reimbursement, payer policies and patient financial assistance | ACTIVE | — |
| 038 | Electronic data interchange services in the field of healthcare transactions such as claims, eligibility, claim status, electronic remittance advice, prior authorizations, attachments, and referrals that allow direct transaction and payment communications between healthcare providers, pharmacies, and payers | ACTIVE | — |
| 042 | Providing temporary use of a web-based software application for use in providing support for pharmacies and health systems that integrates with pharmacy management systems to facilitate dispensing of pharmaceuticals via remote prescription verification, audit trails with images of dispensed drug, alerts to avoid duplicate patient therapy, allergies, and drug interactions; Software as a service (SAAS) services featuring software for facilitating the prescription of, and access to covered specialty medications and medical treatments by enabling intra provider-insurer-pharmacy communications for purposes of investigating and verifying patient-specific benefits coverage, for processing prior medical authorizations, for locating and facilitating patient access to financial assistance, for scheduling laboratory tests and first dose observations, for transmitting prescriptions to a patient's preferred pharmacy, and for supporting pharmaceutical companies in risk evaluation and mitigation strategy programs, and, as related to the above, specifically excluding software permitting health care providers and patients to communicate via a customized private website to collect, analyze, manage, share, report or compare patient data, rehabilitation tracking and patient progress; Software as a service featuring software for integration of medical software with drug interaction references and recommendations from medical databases; Software as a service (SAAS) namely, hosting an online software platform for use by others that provides online price comparisons, cost analysis, coupons, and price quotations of pharmaceuticals and over the counter medications for consumers, providers, administrators, and other participants in the healthcare industry; Software as a service (SAAS) services featuring software for use by medical care providers, pharmacists, and benefit providers for utilizing, aggregating, analyzing, displaying, and updating medical health record data analytics, for use in prior authorization support, prescription benefit support, prescription decision support, and medical care support to improve clinical outcomes; Software as a service (SAAS) services featuring software for the purpose of integrating medical information in the fields of pharmaceuticals, drug interactions, and treatment guidelines for the purpose of reducing the time and effort required from all stakeholders to start specialty therapy with the goal of improving patient outcomes | ACTIVE | — |
| 044 | Providing medical advice and information about medication, access to medical care, medication insurance coverage, benefits verification, reimbursement, payer policies and patient financial assistance; medication counseling, namely providing information about taking medication, medication side-effects, allergic sensitivity to medications, drug interactions, medication tolerance, and alternate medication brands and generics | ACTIVE | — |
| 045 | Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CoverMyMeds LLC
- Other trademarks owned by CoverMyMeds LLC
- Other trademarks owned by CoverMyMeds LLC
- Other trademarks in Class 036
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named COVERMYMEDS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 31, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 31, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 11, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 11, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 11, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 12, 2024 | IUAF | USE AMENDMENT FILED | — |
| Jun 12, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 12, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 12, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 12, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 12, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Dec 12, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 17, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 17, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 27, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 10, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 9, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 8, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 8, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 8, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 8, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 8, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 8, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 7, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 30, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 30, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 30, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 16, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 12, 2021 | NWAP | NEW APPLICATION ENTERED | — |